These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17106820)

  • 1. Efficacy of oral anticancer agents for colorectal cancer.
    Sakamoto J; Oba K; Matsui T; Kobayashi M
    Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S82-91. PubMed ID: 17106820
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapy.
    Bennouna J; Douillard JY
    Expert Rev Anticancer Ther; 2003 Aug; 3(4):505-17. PubMed ID: 12934662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of adjuvant therapy for colorectal cancer: are we overtreating our patients?
    Gill S; Goldberg RM
    Nat Clin Pract Oncol; 2005 Jun; 2(6):276-7. PubMed ID: 16264965
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in the medical treatment of advanced colorectal cancer.
    Fabre-Guillevin E; Piedbois P; Buyse M
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):711-6. PubMed ID: 14599093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination effects of SC144 and cytotoxic anticancer agents.
    Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
    Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
    Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
    Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytoreductive surgery and intraperitoneal chemotherapy in colorectal cancer].
    Fischer A
    Ugeskr Laeger; 2007 Sep; 169(38):3177. PubMed ID: 17910823
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Sabharwal A; Kerr D
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.
    Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Oida Y; Nakamura M; Makuuchi H
    Oncol Rep; 2008 Nov; 20(5):1189-94. PubMed ID: 18949420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.
    Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Nakamura M; Makuuchi H
    Oncol Rep; 2008 Dec; 20(6):1521-6. PubMed ID: 19020736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
    Mandalà M; Mosconi S; Quadri A; Milesi L; Labianca R
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):887-97. PubMed ID: 17555399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer chemotherapy.
    Woodcock TM
    J Ky Med Assoc; 2009 Mar; 107(3):93-4. PubMed ID: 19361080
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorectal cancer.
    Zalcberg JR
    Med J Aust; 1999 Mar; 170(6):283; author reply 284. PubMed ID: 10212653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Team-based medical care can improve tailor made chemotherapy for colorectal cancer].
    Muneoka K; Shirai Y; Sasaki M; Kanda J; Asakura T; Wakabayashi H; Toshima M; Hatakeyama K
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1883-7. PubMed ID: 19011336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
    Jover R; Zapater P; Castells A; Llor X; Andreu M; Cubiella J; Balaguer F; Sempere L; Xicola RM; Bujanda L; Reñé JM; Clofent J; Bessa X; Morillas JD; Nicolás-Pérez D; Pons E; Payá A; Alenda C;
    Eur J Cancer; 2009 Feb; 45(3):365-73. PubMed ID: 18722765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.